Anticoagulation therapy versus placebo for pulmonary hypertension (Q24194138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

main subject

placebo

0 references

arterial hypertension

1 reference

1 reference

pulmonary hypertension

1 reference

Ifeanyi R Ezedunukwe

1

Ifeanyi R

Ezedunukwe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

Hilary Enuh

series ordinal

2

author given names

Hilary

author last names

Enuh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

Jay Nfonoyim

series ordinal

3

author given names

Jay

author last names

Nfonoyim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

Collins U Enuh

series ordinal

4

author given names

Collins U

author last names

Enuh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

3 June 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

page(s)

CD010695

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

Regression in thromboembolic type of primary pulmonary hypertension during 2 1/2 years of antithrombotic therapy.

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

The Effect of Anticoagulant Therapy in Primary and Anorectic Drug-Induced Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

New predictors of outcome in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Diagnosis and assessment of pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Cellular and molecular pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Bosentan and warfarin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Risk of alveolar hemorrhage in patients with primary pulmonary hypertension--anticoagulation and epoprostenol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

An epidemiological study of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Pathologic assessment of vasculopathies in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

A USA-based registry for pulmonary arterial hypertension: 1982-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD010695.PUB2

Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome

21 January 2018

1 reference

12 December 2020

Lung biopsy specimens in the evaluation of pulmonary vascular disease

1 reference

12 December 2020

Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction

1 reference

12 December 2020

[Fibrinolytic herapy of severe pulmonary hypertension. Justification, modality an criticism]

1 reference

12 December 2020

Results of one-year anticoagulation in patients with newly detected chronic thromboembolic pulmonary hypertension not treated with pulmonary endarterectomy.

1 reference

12 December 2020

Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension

1 reference

12 December 2020

Primary Pulmonary Hypertension with Emphasis on its Etiology and Treatment

1 reference

12 December 2020

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

1 reference

12 December 2020

Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension.

1 reference

12 December 2020

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

12 December 2020

Thrombotic arteriopathy and anticoagulation in pulmonary hypertension

1 reference

12 December 2020

Anticoagulation therapy in pulmonary arterial hypertension

1 reference

12 December 2020

Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling

1 reference

12 December 2020

Primary pulmonary hypertension: a histopathologic study of 80 cases

1 reference

12 December 2020

10.1002/14651858.CD010695.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

release_cohuvnkb3rhiva53rjrdtaacnu

13 May 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6885066&resulttype=core&format=json

13 May 2020

PubMed publication ID

24887213

1 reference